Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Paramount Raises Bid for Warner Bros., Escalating Studio Showdown With Netflix

by Team Lumida
24 hours ago
Paramount Raises Bid for Warner Bros., Escalating Studio Showdown With Netflix

Key takeaways Powered by lumidawealth.com Paramount Skydance Corp submitted a higher bid for Warner Bros. Discovery Inc., topping its prior $30/share offer. Warner had agreed in December to sell...

Read more

Private Equity’s Exit Drought Deepens: Distributions Stall, Fundraising Slides, and the “Hold Period” Problem Grows

by Team Lumida
2 days ago
Private Equity’s Exit Drought Deepens: Distributions Stall, Fundraising Slides, and the “Hold Period” Problem Grows

Key takeaways Powered by lumidawealth.com Liquidity remains constrained: Distributions were 14% of NAV in 2025, the second-lowest level since the depths of the 2008-era slump. Exit overhang is large:...

Read more

JPMorgan Seeks to Dismiss Trump’s $5B Lawsuit, Cites Improper Legal Claims Against Dimon

by Team Lumida
5 days ago
JPMorgan Seeks to Dismiss Trump’s $5B Lawsuit, Cites Improper Legal Claims Against Dimon

Key takeaways Powered by lumidawealth.com JPMorgan Chase is seeking to dismiss Donald Trump’s lawsuit, alleging improper inclusion of Jamie Dimon in the suit to circumvent federal jurisdiction. The lawsuit...

Read more

Amazon Overtakes Walmart to Become America’s Largest Company by Revenue

by Team Lumida
5 days ago
Amazon’s $100 Billion Bet: AI Over Retail

Key takeaways Powered by lumidawealth.com Amazon's revenue reached $716.9 billion for the year, surpassing Walmart’s $713.2 billion, ending Walmart’s 17-year reign as the largest U.S. company by revenue. Amazon’s...

Read more

Foreign Investors Defy “Sell America,” Buy $1.6T Net of US Assets in 2025

by Team Lumida
6 days ago
flag of U.S.A. under white clouds during daytime

Key takeaways Powered by lumidawealth.com Foreign investors bought $1.55T net of long-term US assets in 2025 (vs $1.18T in 2024), led by equities ($658.5B) and Treasuries ($442.7B). The data...

Read more

Meta Under Fire in California Trial Over Teen Harm, “Time Spent” Goals, and Underage Users

by Team Lumida
6 days ago
a bunch of stickers on the side of a building

Key Takeaways Powered by lumidawealth.com Zuckerberg faced questioning on internal discussions about increasing “time spent,” including a 2015 email targeting a 12% increase. Meta says it no longer gives...

Read more

Uber Commits $100M+ to Robotaxi Charging Hubs, Moving Closer to “Platform + Infrastructure” Control

by Team Lumida
7 days ago
A close up of a car's tail light

Key Takeaways Powered by lumidawealth.com Uber plans to invest $100M+ in high-capacity fast-charging hubs for autonomous vehicles, starting in the Bay Area, Los Angeles, and Dallas. Charging ownership is...

Read more

Berkshire Dumps Most of Amazon, Adds New York Times in Late-Stage Portfolio Shift

by Team Lumida
7 days ago
Berkshire Dumps Most of Amazon, Adds New York Times in Late-Stage Portfolio Shift

Key Takeaways Powered by lumidawealth.com Berkshire Hathaway reduced its Amazon position by more than 75% in Q4, continuing a broader portfolio reshuffle. The firm initiated a new stake in...

Read more

Private Equity Targets America’s $14T 401(k) Pool as Regulators Open the Door to Alternatives

by Team Lumida
7 days ago
Private Equity Targets America’s $14T 401(k) Pool as Regulators Open the Door to Alternatives

Key Takeaways Powered by lumidawealth.com Private equity is moving aggressively into the 401(k) ecosystem by acquiring advisers, consultants, administrators, and recordkeepers that control plan menus and participant access. Policy...

Read more

Apple Breaks From Big Tech Pack as AI Volatility Drives Investors Toward Safety

by Team Lumida
7 days ago
Apple Breaks From Big Tech Pack as AI Volatility Drives Investors Toward Safety

Key Takeaways Powered by lumidawealth.com Apple’s correlation with the Nasdaq 100 fell to 0.21, the lowest since 2006, as it diverges from AI-driven tech volatility. Investors increasingly view Apple...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

June 30, 2024
Ozempic: The GLP-1 Franchise Still Printing—But the Growth Model Is Getting Harder

Ozempic: The GLP-1 Franchise Still Printing—But the Growth Model Is Getting Harder

February 6, 2026
Citizens Financial Group Q4 2024 Earnings Analysis

Citizens Financial Group Q4 2024 Earnings Analysis

January 18, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018